---
created: 2025-04-13
updated: 2025-04-13T10:52
id: N4!x]%#_?/
specialty: neuro
specialty_id: 234
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::15-neuro::07-other::04-delirium-&-dementia
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::11-neurodegenerative-disease-therapy
  - "source/ak-step1-v11:": 
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::11-neurodegenerative-disease-therapy::alzheimers::memantine
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::10-neurology::06-dementia
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::14-neuro::13-alzheimer-disease-treatment-(donepezil,-rivastigmine,-galantamine,-memantine)
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::15-other-neuro::memantine
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::06-neuro/psych::fa-neuro
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1442
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::!shelf::fm::no-dupes
  - source/ak-step2-v11::!shelf::neuro::no-dupes
  - source/ak-step2-v11::!shelf::psych::no-dupes
  - "source/ak-step2-v11:": 
  - theme/ome::10-neurology::06-dementia
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::fm::ome::neuro::dementia
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::neuro::ome::dementia
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::psych::fapsych::neurocognitive-disorders
  - "source/ak-step2-v11:": 
  - theme/uworld::10000-99999::19000-19999::19670
  - source/ak-step2-v11::original-decks::dorian::fam::ome::neuro::dementia
  - source/ak-step2-v11::original-decks::dorian::neuro::ome::dementia
  - source/ak-step2-v11::original-decks::dorian::psych::fapsych::neurocognitive-disorders"
type: flashcard
---

# Question
**Memantine** is a(n) **NMDA** receptor antagonist used to treat **Alzheimer's** disease

---

# Answer
side effects include dizziness, confusion, hallucinations  Therefore, higher extracellular magnesium levels block the NMDA channel, decreasing the influx of calcium and sodium to inhibit glutamate-mediated neuron depolarization.  This vicious cycle of depolarization (excitotoxicity) and glutamate release has been identified as a final common pathway of brain tissue loss (eg, ischemic stroke, traumatic brain injury, Alzheimer dementia).